HCA Healthcare, Inc. (NYSE:HCA) Major Shareholder Purchases $39,942.40 in Stock

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) major shareholder Of America Corp /De/ Bank purchased 1,580 shares of the firm’s stock in a transaction dated Thursday, March 8th. The stock was bought at an average cost of $25.28 per share, for a total transaction of $39,942.40. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

HCA Healthcare Price Performance

Shares of HCA opened at $342.25 on Monday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm has a market cap of $84.26 billion, a PE ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. The firm has a fifty day simple moving average of $324.53 and a two-hundred day simple moving average of $340.92.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm posted $5.90 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s payout ratio is presently 13.11%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Truist Financial dropped their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Bank of America reduced their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Royal Bank of Canada decreased their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $385.67.

View Our Latest Stock Analysis on HCA Healthcare

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in HCA. Legacy Investment Solutions LLC purchased a new position in HCA Healthcare during the third quarter valued at $39,000. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare in the fourth quarter worth about $31,000. Tidemark LLC purchased a new position in HCA Healthcare during the 4th quarter valued at approximately $36,000. Activest Wealth Management raised its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its holdings in shares of HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.